Firvanq Kit
Product Images NDC 65628-205

6 FDA label images from Azurity Pharmaceuticals, Inc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Firvanq (NDC 65628-205). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Azurity Pharmaceuticals, Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image 01

Image 01
Chemical structure of vancomycin hydrochloride, the active ingredient in FIRVANQ, showing the detailed molecular arrangement including rings, hydroxyl groups, amide bonds, and chloride ions.*
FDA Label Image

Image 02

FDA Label Image

Image 03

Image 03
FIRVANQ vancomycin hydrochloride 25 mg/mL Kit packaging label for oral solution. The front panel shows the product name, dosage strength, and kit components including vancomycin hydrochloride powder and grape flavored diluent. It is manufactured by Azurity Pharmaceuticals, Inc. The label includes storage instructions, reconstitution directions, and pharmacist information. The kit has a final volume of 150 mL after reconstitution and must be refrigerated.*
FDA Label Image

Image 04

Image 04
FIRVANQ vancomycin hydrochloride for oral solution 25 mg/mL kit packaging label. The kit contains one bottle of vancomycin hydrochloride powder and one bottle of grape flavored diluent for reconstitution, totaling 300 mL after reconstitution. Manufactured for Azurity Pharmaceuticals, Inc, the label instructs storage in refrigeration and use for oral administration only.*
FDA Label Image

Image 05

Image 05
FIRVANQ vancomycin hydrochloride 50 mg/mL oral solution kit packaging label. The 150 mL kit includes vancomycin hydrochloride powder and grape flavored diluent for reconstitution. The label displays instructions to pharmacists, storage requirements, and the Azurity Pharmaceuticals logo. It indicates the product is for oral use only and must be refrigerated after reconstitution.*
FDA Label Image

Image 06

Image 06
FIRVANQ vancomycin hydrochloride for oral solution kit, containing Vancomycin 50 mg/mL. The label indicates a kit with one bottle of 15.4 g Vancomycin Hydrochloride powder and one bottle of 289 mL grape-flavored diluent for reconstitution, with a final volume of 300 mL. Manufactured by Azurity Pharmaceuticals, Inc., the label includes pharmacist preparation instructions and storage requirements.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.